{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T13:46:29Z","timestamp":1790257589681,"version":"4.1.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1016\/j.ijrobp.2010.12.002","type":"journal-article","created":{"date-parts":[[2011,2,7]],"date-time":"2011-02-07T04:11:22Z","timestamp":1297051882000},"page":"974-980","source":"Crossref","is-referenced-by-count":113,"title":["Prediction of Chest Wall Toxicity From Lung Stereotactic Body Radiotherapy (SBRT)"],"prefix":"10.1016","volume":"82","author":[{"given":"Kevin L.","family":"Stephans","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toufik","family":"Djemil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul D.","family":"Tendulkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cliff G.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandana A.","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory M.M.","family":"Videtic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2010.12.002_bib1","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1080\/02841860600904862","article-title":"Factors important for efficacy of stereotactic body radiotherapy of medically inoperable stage I lung cancer. A retrospective analysis of patients treated in the Nordic countries","volume":"45","author":"Baumann","year":"2006","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ijrobp.2010.12.002_bib2","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ijrobp.2005.11.028","article-title":"Stereotactic body radiation therapy for nonmetastatic lung cancer: An analysis of 75 patients treated over 5 years","volume":"65","author":"Beitler","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.12.002_bib3","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ijrobp.2008.06.1939","article-title":"Dose-response relationship for image-guided stereotactic body radiotherapy of pulmonary tumors: Relevance of 4D dose calculation","volume":"74","author":"Guckenberger","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.12.002_bib4","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.ijrobp.2007.10.053","article-title":"Outcomes of risk-adapted fractionated stereotactic radiotherapy for stage I non-small-cell lung cancer","volume":"70","author":"Lagerwaard","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.12.002_bib5","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ijrobp.2008.03.062","article-title":"Observation of a dose-control relationship for lung and liver tumors after stereotactic body radiation therapy","volume":"73","author":"McCammon","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.12.002_bib6","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/j.ijrobp.2005.05.034","article-title":"Clinical outcomes of a phase I\/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame","volume":"63","author":"Nagata","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.12.002_bib7","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.radonc.2008.02.015","article-title":"Hypofractionated stereotactic radiotherapy for medically inoperable stage I non-small cell lung cancer\u2014Report on clinical outcome and dose to critical organs","volume":"87","author":"Ng","year":"2008","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2010.12.002_bib8","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.lungcan.2005.08.011","article-title":"Stereotactic hypofractionated radiotherapy for stage I non-small cell lung cancer\u2014Mature results for medically inoperable patients","volume":"51","author":"Nyman","year":"2006","journal-title":"Lung Cancer"},{"key":"10.1016\/j.ijrobp.2010.12.002_bib9","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1080\/02841860600908954","article-title":"Stereotactic Body Radiation Therapy (SBRT) for lung metastases","volume":"45","author":"Okunieff","year":"2006","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ijrobp.2010.12.002_bib10","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S0360-3016(03)00095-6","article-title":"Tolerance of organs at risk in small-volume, hypofractionated, image-guided radiotherapy for primary and metastatic lung cancers","volume":"56","author":"Onimaru","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.12.002_bib11","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1097\/JTO.0b013e318074de34","article-title":"Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: Updated results of 257 patients in a Japanese multi-institutional study","volume":"2","author":"Onishi","year":"2007","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.ijrobp.2010.12.002_bib12","doi-asserted-by":"crossref","first-page":"4833","DOI":"10.1200\/JCO.2006.07.5937","article-title":"Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer","volume":"24","author":"Timmerman","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2010.12.002_bib13","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1378\/chest.124.5.1946","article-title":"Extracranial stereotactic radioablation: Results of a phase I study in medically inoperable stage I non-small cell lung cancer","volume":"124","author":"Timmerman","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.ijrobp.2010.12.002_bib14","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/S0360-3016(01)01703-5","article-title":"Computed tomography-guided frameless stereotactic radiotherapy for stage I non-small cell lung cancer: A 5-year experience","volume":"51","author":"Uematsu","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.12.002_bib15","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.radonc.2005.09.003","article-title":"Dose-response in stereotactic irradiation of lung tumors","volume":"77","author":"Wulf","year":"2005","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2010.12.002_bib16","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.ijrobp.2008.08.036","article-title":"Acute skin toxicity following stereotactic body radiation therapy for stage I non-small-cell lung cancer: Who\u2019s at risk?","volume":"72","author":"Hoppe","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.12.002_bib17","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.ijrobp.2009.02.027","article-title":"Chest wall volume receiving >30 Gy predicts risk of severe pain and\/or rib fracture after lung stereotactic body radiotherapy","volume":"76","author":"Dunlap","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.12.002_bib18","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.radonc.2009.03.022","article-title":"Radiation-induced rib fractures after hypofractionated stereotactic body radiation therapy of non-small cell lung cancer: A dose- and volume-response analysis","volume":"91","author":"Pettersson","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2010.12.002_bib19","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1097\/JTO.0b013e3181adf509","article-title":"A comparison of two stereotactic body radiation fractionation schedules for medically inoperable stage I non-small cell lung cancer: The Cleveland Clinic experience","volume":"4","author":"Stephans","year":"2009","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.ijrobp.2010.12.002_bib20","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1097\/JTO.0b013e3181ae2962","article-title":"Chest wall pain and rib fracture after stereotactic radiotherapy for peripheral non-small cell lung cancer","volume":"4","author":"Voroney","year":"2009","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.ijrobp.2010.12.002_bib21","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.ijrobp.2008.08.072","article-title":"Extrapulmonary soft-tissue fibrosis resulting from hypofractionated stereotactic body radiotherapy for pulmonary nodular lesions","volume":"74","author":"Kawase","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.12.002_bib22","unstructured":"http:\/\/www.rtog.org\/members\/protocols\/0236\/0236.pdf."},{"key":"10.1016\/j.ijrobp.2010.12.002_bib23","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.ijrobp.2007.10.059","article-title":"Universal survival curve and single fraction equivalent dose: Useful tools in understanding potency of ablative radiotherapy","volume":"70","author":"Park","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.12.002_bib24","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S1547-4127(04)00022-2","article-title":"Postthoracotomy pain syndrome","volume":"14","author":"Karmakar","year":"2004","journal-title":"Thorac Surg Clin"},{"key":"10.1016\/j.ijrobp.2010.12.002_bib25","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/cncr.21999","article-title":"Late gastrointestinal toxicity after radiation for prostate cancer","volume":"107","author":"Giordano","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2010.12.002_bib26","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s10549-006-9480-9","article-title":"Predictive factors for late normal tissue complications following radiotherapy for breast cancer","volume":"106","author":"Lilla","year":"2007","journal-title":"Breast Cancer Res Treat"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301610036345?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301610036345?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,4]],"date-time":"2018-12-04T19:58:53Z","timestamp":1543953533000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301610036345"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S0360301610036345"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2010.12.002","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]}}}